{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:20:24Z","timestamp":1758478824650},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T00:00:00Z","timestamp":1402099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s12032-014-0044-2","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T05:03:01Z","timestamp":1402030981000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in thymic carcinoma diagnosis and treatment: a review of literature"],"prefix":"10.1007","volume":"31","author":[{"given":"J.","family":"Syrios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fergadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Logothetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0399.","family":"Iakovidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,7]]},"reference":[{"issue":"10 Suppl 4","key":"44_CR1","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260\u20135.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"44_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejcts.2009.05.038","volume":"37","author":"F Venuta","year":"2010","unstructured":"Venuta F, et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg. 2010;37(1):13\u201325.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"44_CR3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","volume":"95","author":"G Chen","year":"2002","unstructured":"Chen G, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95(2):420\u20139.","journal-title":"Cancer"},{"issue":"5","key":"44_CR4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jtcvs.2005.07.026","volume":"130","author":"CD Wright","year":"2005","unstructured":"Wright CD, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg. 2005;130(5):1413\u201321.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"44_CR5","doi-asserted-by":"crossref","unstructured":"Marx A, et al. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin 2011;21(1):25\u201331, v\u2013vi.","DOI":"10.1016\/j.thorsurg.2010.08.010"},{"issue":"3","key":"44_CR6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","volume":"59","author":"TY Eng","year":"2004","unstructured":"Eng TY, et al. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys. 2004;59(3):654\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"44_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.hoc.2008.03.002","volume":"22","author":"CA Moran","year":"2008","unstructured":"Moran CA, Suster S. Thymic carcinoma: current concepts and histologic features. Hematol Oncol Clin North Am. 2008;22(3):393\u2013407.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"44_CR8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.hoc.2008.03.006","volume":"22","author":"AM Marchevsky","year":"2008","unstructured":"Marchevsky AM, McKenna RJ Jr, Gupta R. Thymic epithelial neoplasms: a review of current concepts using an evidence-based pathology approach. Hematol Oncol Clin North Am. 2008;22(3):543\u201362.","journal-title":"Hematol Oncol Clin North Am"},{"key":"44_CR9","unstructured":"Thymomas and Thymic Carcinomas: NCCN Guidelines Version 1.2014."},{"issue":"7","key":"44_CR10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","volume":"17","author":"CR Thomas","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999;17(7):2280\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"44_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.hoc.2008.03.011","volume":"22","author":"ML Rosado-de-Christenson","year":"2008","unstructured":"Rosado-de-Christenson ML, Strollo DC, Marom EM. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin North Am. 2008;22(3):409\u201331.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"44_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11604-005-1530-4","volume":"24","author":"A Inoue","year":"2006","unstructured":"Inoue A, et al. MR imaging of thymic epithelial tumors: correlation with World Health Organization classification. Radiat Med. 2006;24(3):171\u201381.","journal-title":"Radiat Med"},{"issue":"1","key":"44_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/ar.2012.120536","volume":"54","author":"P Sharma","year":"2013","unstructured":"Sharma P, et al. Evaluation of thymic tumors with 18F-FDG PET\u2013CT: a pictorial review. Acta Radiol. 2013;54(1):14\u201321.","journal-title":"Acta Radiol"},{"issue":"12","key":"44_CR14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hye136","volume":"31","author":"A Kitami","year":"2001","unstructured":"Kitami A, et al. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature. Jpn J Clin Oncol. 2001;31(12):601\u20134.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"44_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hoc.2008.03.003","volume":"22","author":"PE Wakely Jr","year":"2008","unstructured":"Wakely PE Jr. Fine needle aspiration in the diagnosis of thymic epithelial neoplasms. Hematol Oncol Clin North Am. 2008;22(3):433\u201342.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"44_CR16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00000478-199812000-00004","volume":"22","author":"TT Kuo","year":"1998","unstructured":"Kuo TT, Chan JK. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol. 1998;22(12):1474\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"44_CR17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","volume":"77","author":"K Kondo","year":"2004","unstructured":"Kondo K, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77(4):1183\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"44_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.critrevonc.2007.04.005","volume":"65","author":"CD Wright","year":"2008","unstructured":"Wright CD. Management of thymomas. Crit Rev Oncol Hematol. 2008;65(2):109\u201320.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"44_CR19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/modpathol.2009.105","volume":"22","author":"M Kojika","year":"2009","unstructured":"Kojika M, et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol. 2009;22(10):1341\u201350.","journal-title":"Mod Pathol"},{"issue":"9","key":"44_CR20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/annonc\/mdr626","volume":"23","author":"L Schirosi","year":"2012","unstructured":"Schirosi L, et al. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. Ann Oncol. 2012;23(9):2409\u201314.","journal-title":"Ann Oncol"},{"issue":"10","key":"44_CR21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bjc.1997.561","volume":"76","author":"N Hino","year":"1997","unstructured":"Hino N, et al. High frequency of p53 protein expression in thymic carcinoma but not in thymoma. Br J Cancer. 1997;76(10):1361\u20136.","journal-title":"Br J Cancer"},{"issue":"12","key":"44_CR22","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/annonc\/mds147","volume":"23","author":"T Mimae","year":"2012","unstructured":"Mimae T, et al. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Ann Oncol. 2012;23(12):3129\u201337.","journal-title":"Ann Oncol"},{"issue":"36","key":"44_CR23","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","volume":"29","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, et al. Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol. 2011;29(36):4820\u20137.","journal-title":"J Clin Oncol"},{"issue":"11","key":"44_CR24","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485\u201392.","journal-title":"Cancer"},{"issue":"Suppl 3","key":"44_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/annonc\/11.suppl_3.245","volume":"11","author":"G Giaccone","year":"2000","unstructured":"Giaccone G. Treatment of thymoma and thymic carcinoma. Ann Oncol. 2000;11(Suppl 3):245\u20136.","journal-title":"Ann Oncol"},{"issue":"6","key":"44_CR26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","volume":"76","author":"K Kondo","year":"2003","unstructured":"Kondo K, Monden Y. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg. 2003;76(6):1859\u201364 discussion 1864\u20135.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"44_CR27","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2012.01.014","volume":"93","author":"IC Okereke","year":"2012","unstructured":"Okereke IC, et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg. 2012;93(5):1668\u201372 discussion 1672\u20133.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"44_CR28","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;22(8):1501\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"44_CR29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","volume":"67","author":"S Suster","year":"1991","unstructured":"Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67(4):1025\u201332.","journal-title":"Cancer"},{"issue":"3","key":"44_CR30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.hoc.2008.03.009","volume":"22","author":"LR Kaiser","year":"2008","unstructured":"Kaiser LR. Surgical treatment of thymic epithelial neoplasms. Hematol Oncol Clin North Am. 2008;22(3):475\u201388.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"44_CR31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jso.20671","volume":"95","author":"M Okumura","year":"2007","unstructured":"Okumura M, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to world health organization histologic classification system. J Surg Oncol. 2007;95(1):40\u20134.","journal-title":"J Surg Oncol"},{"issue":"3","key":"44_CR32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.hoc.2008.03.012","volume":"22","author":"CD Fuller","year":"2008","unstructured":"Fuller CD, Housman DM, Thomas CR. Radiotherapy for thymoma and thymic carcinoma. Hematol Oncol Clin North Am. 2008;22(3):489\u2013507.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10 Suppl 4","key":"44_CR33","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1097\/JTO.0b013e3181f20ec4","volume":"5","author":"CD Fuller","year":"2010","unstructured":"Fuller CD, et al. Radiotherapy for thymic neoplasms. J Thorac Oncol. 2010;5(10 Suppl 4):S327\u201335.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"44_CR34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","volume":"46","author":"M Myojin","year":"2000","unstructured":"Myojin M, et al. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys. 2000;46(4):927\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"44_CR35","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cncr.10373","volume":"94","author":"K Ogawa","year":"2002","unstructured":"Ogawa K, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer. 2002;94(5):1405\u201313.","journal-title":"Cancer"},{"issue":"9","key":"44_CR36","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"PJ Loehrer Sr","year":"1997","unstructured":"Loehrer PJ Sr, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15(9):3093\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"44_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","volume":"68","author":"A Fornasiero","year":"1991","unstructured":"Fornasiero A, et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer. 1991;68(1):30\u20133.","journal-title":"Cancer"},{"issue":"6","key":"44_CR38","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"PJ Loehrer Sr","year":"1994","unstructured":"Loehrer PJ Sr, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol. 1994;12(6):1164\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"44_CR39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 1996;14(3):814\u201320.","journal-title":"J Clin Oncol"},{"issue":"11","key":"44_CR40","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","volume":"91","author":"PJ Loehrer Sr","year":"2001","unstructured":"Loehrer PJ Sr, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer. 2001;91(11):2010\u20135.","journal-title":"Cancer"},{"issue":"3","key":"44_CR41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000421-200206000-00012","volume":"25","author":"T Koizumi","year":"2002","unstructured":"Koizumi T, et al. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy). Am J Clin Oncol. 2002;25(3):266\u20138.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"44_CR42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","volume":"44","author":"ES Kim","year":"2004","unstructured":"Kim ES, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer. 2004;44(3):369\u201379.","journal-title":"Lung Cancer"},{"issue":"5","key":"44_CR43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1010-7940(01)00666-2","volume":"19","author":"M Lucchi","year":"2001","unstructured":"Lucchi M, et al. The multimodality treatment of thymic carcinoma. Eur J Cardiothorac Surg. 2001;19(5):566\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"15","key":"44_CR44","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","volume":"29","author":"GL Lemma","year":"2011","unstructured":"Lemma GL, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011;29(15):2060\u20135.","journal-title":"J Clin Oncol"},{"issue":"2","key":"44_CR45","first-page":"161","volume":"5","author":"M Sakai","year":"2013","unstructured":"Sakai M, et al. Early-stage thymic carcinoma: is adjuvant therapy required? J Thorac Dis. 2013;5(2):161\u20134.","journal-title":"J Thorac Dis"},{"issue":"2","key":"44_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","volume":"22","author":"PJ Loehrer","year":"2004","unstructured":"Loehrer PJ, et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol. 2004;22(2):293\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"44_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lungcan.2010.09.004","volume":"70","author":"Y Okuma","year":"2010","unstructured":"Okuma Y, et al. S-1 is an active anticancer agent for advanced thymic carcinoma. Lung Cancer. 2010;70(3):357\u201363.","journal-title":"Lung Cancer"},{"issue":"6","key":"44_CR48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/annonc\/mdp483","volume":"21","author":"G Palmieri","year":"2010","unstructured":"Palmieri G, et al. Preliminary results of phase II study of capecitabine and gemcitabine (CAP\u2013GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs). Ann Oncol. 2010;21(6):1168\u201372.","journal-title":"Ann Oncol"},{"issue":"2","key":"44_CR49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","volume":"103","author":"P Strobel","year":"2010","unstructured":"Strobel P, et al. Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer. 2010;103(2):196\u2013200.","journal-title":"Br J Cancer"},{"issue":"10 Suppl 4","key":"44_CR50","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1097\/JTO.0b013e3181f21114","volume":"5","author":"A Rajan","year":"2010","unstructured":"Rajan A, Giaccone G. Targeted therapy for advanced thymic tumors. J Thorac Oncol. 2010;5(10 Suppl 4):S361\u20134.","journal-title":"J Thorac Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0044-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0044-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0044-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T05:22:03Z","timestamp":1565500923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0044-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0044-2","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,7]]},"article-number":"44"}}